CAS 1401966-69-5

GSK2879552

CAS: 1401966-69-5

Fórmula: C₂₃H₂₈N₂O₂

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 364.4806

Ref: IN-DA009CI4

GSK2879552

CAS: 1401966-69-5

GSK2879552: oral, irreversible LSD1 inhibitor with potential cancer-fighting properties.

Fórmula: C₂₃H₂₈N₂O₂

Pureza: 99.22%

Cor e Forma: Solid

Peso molecular: 364.48

Ref: TM-T3677

GSK2879552

CAS: 1401966-69-5

GSK2879552 is a chemical compound that inhibits the transcriptional activation of genes. It is a potent competitive inhibitor of histone deacetylases (HDACs) and has been shown to inhibit the growth of leukemia cells in vitro. GSK2879552 is also an inhibitor of protein kinase C (PKC), which plays an important role in the regulation of signal transduction pathways, and can inhibit PKC-induced phosphorylation of JNK1 and p38 MAPK. GSK2879552 has shown potential as a biomarker for monitoring the effectiveness of platinum-based chemotherapy in patients with advanced cancer.

Pureza: Min. 95%

Ref: 3D-BG170574